Medicare Enrolled
Dr. Muna Jabbour, M.D.
Internal Medicine · New Stanton, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jabbour from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jabbour?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jabbour
Dr. Muna Jabbour is an internal medicine specialist in New Stanton, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Jabbour performed 2,588 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Jabbour received a total of $11,032 from 43 pharmaceutical and/or device companies across 540 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jabbour is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in PA
$11,032 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,588
Medicare services
Top 7% in PA for internal medicine
Not available
Unique patients (not deduplicated)
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,574 | $61 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
200 | $77 | $150 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
140 | $81 | $126 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
92 | $88 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
89 | $133 | $290 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
75 | $139 | $235 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
62 | $56 | $122 |
| Annual depression screening | 59 | $17 | $25 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
56 | $123 | $250 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
53 | $29 | $30 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
53 | $29 | $31 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $59 | $100 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
32 | $26 | $81 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
30 | $196 | $250 |
| Nursing facility discharge management, more than 30 minutes This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities. |
21 | $93 | $134 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $117 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,032
Total received (2018-2024)
Avg $1,576/year across 7 years
Top 7% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
540
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,839
2023
$2,167
2022
$1,434
2021
$1,925
2020
$1,083
2019
$1,184
2018
$1,400
Payments by company (2024)
ABBVIE INC.
$271
AstraZeneca Pharmaceuticals LP
$257
Otsuka America Pharmaceutical, Inc.
$215
Novo Nordisk Inc
$198
AIMMUNE THERAPEUTICS, INC.
$139
Lilly USA, LLC
$130
PFIZER INC.
$118
Galderma Laboratories, L.P.
$88
Abbott Laboratories
$78
MERZ NORTH AMERICA, INC.
$65
Merck Sharp & Dohme LLC
$50
GlaxoSmithKline, LLC.
$31
E.R. Squibb & Sons, L.L.C.
$31
ACADIA Pharmaceuticals Inc
$27
Neurocrine Biosciences, Inc.
$27
UCB, Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Exact Sciences Corporation
$17
Novartis Pharmaceuticals Corporation
$17
Astellas Pharma US Inc
$16
Top 3 companies account for 40.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,513
ABBVIE INC.
$1,211
AstraZeneca Pharmaceuticals LP
$750
PFIZER INC.
$658
Lilly USA, LLC
$597
Abbott Laboratories
$510
Janssen Pharmaceuticals, Inc
$421
E.R. Squibb & Sons, L.L.C.
$347
AbbVie Inc.
$330
Merz North America, Inc.
$293
Otsuka America Pharmaceutical, Inc.
$231
Allergan Inc.
$230
Allergan, Inc.
$221
GlaxoSmithKline, LLC.
$221
SANOFI-AVENTIS U.S. LLC
$200
Astellas Pharma US Inc
$190
Merck Sharp & Dohme Corporation
$183
Bayer HealthCare Pharmaceuticals Inc.
$170
Xeris Pharmaceuticals, Inc.
$160
Galderma Laboratories, L.P.
$144
AIMMUNE THERAPEUTICS, INC.
$139
IDORSIA PHARMACEUTICALS US INC
$125
Amgen Inc.
$123
Kowa Pharmaceuticals America, Inc.
$122
Exact Sciences Corporation
$112
UCB, Inc.
$92
Merck Sharp & Dohme LLC
$88
Neurelis, Inc.
$83
Sunovion Pharmaceuticals Inc.
$74
MERZ NORTH AMERICA, INC.
$65
Novartis Pharmaceuticals Corporation
$63
Bayer Healthcare Pharmaceuticals Inc.
$53
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$52
Seqirus USA Inc
$42
DEXCOM, INC.
$42
Nestle HealthCare Nutrition Inc.
$28
ACADIA Pharmaceuticals Inc
$27
Neurocrine Biosciences, Inc.
$27
Amarin Pharma Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Collegium Pharmaceutical, Inc.
$17
Daiichi Sankyo Inc.
$15
Orexo US, Inc.
$13
Top 3 companies account for 40.6% of all-time payments
Associated products mentioned in payments ›
ANORO · APTIOM · AVYCAZ · Aimovig · BAQSIMI · BOTOX · BREZTRI · Briviact · CHANTIX · COLOGUARD · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GVOKE PFS · HUMALOG · INGREZZA · INJECTAFER · JANUVIA · JARDIANCE · Kerendia · LINZESS · LOKELMA · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NUPLAZID · NURTEC ODT · Nayzilam · Ozempic · PNEUMOVAX 23 · PRALUENT · PREVNAR 13 · PREVNAR 20 · PROCLAIM · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SHINGRIX · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYMBICORT · TEFLARO · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · Utibron · VALTOCO · VIIBRYD · VOWST · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xeomin · Xultophy 100/3.6 · ZENPEP · ZEPBOUND
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
956
County median income
$72,468
Nearest hospital to ZIP centroid (approximate)
EXCELA HEALTH WESTMORELAND REGIONAL HOSPITAL
6.6 mi
6.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jabbour is a clinical cardiology specialist, with above-average Medicare volume (top 7% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jabbour experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Jabbour performed 1,574 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jabbour receive payments from pharmaceutical companies?
Yes. Dr. Jabbour received a total of $11,032 from 43 companies across 540 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jabbour's costs compare to other internal medicine physicians in New Stanton?
Dr. Jabbour's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jabbour) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in New Stanton
Browse internal medicine physicians in New Stanton ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology